JeanMarie Guenot: Ph.D. With an Aim For Fighting Cancer

What does it take to run a hospital efficiently? With multiple departments dedicated to multiple health concerns, how is one person supposed to keep track of everything that goes on? The answer, one person doesn’t. It takes a team of managers to properly run a hospital. And what’s the most important part of hospital’s operation?

While most would say patient health care, the correct answer is the financial department. It’s because of professionals like JeanMarie Guenot, Ph.D. that hospitals are able to operate at all. As for JeanMarie Guenot, herself, she has over 20 years of experience managing healthcare facilities on takeda.com. She also has experience in both the pharmaceutical and biotechnology industries.

Her experience in the medical field has mostly been behind the scenes managing. Her skill set expands across all stages of public and private companies at http://amphivena.com/amphivena_leaders/jeanmarie-guenot-ph-d/. She’s also worked closely with several different specialized departments, including pharmaceutical research and development, corporate and commercial development, individual business development, project and alliance team management, and venture capitals. Her particular talents have made her one of the most recognized professionals in her field.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Before becoming the successful CEO and president of Amphivena Therapeutics, Inc., Jeanmarie Guenot founded her own company, SKS Ocular. SKS Ocular developed therapies and technology that treated patients with glaucoma, macular degeneration, and ocular inflammation. Most of its medical contributions still exist to this day. She was also a business advisor for Hoffman-La Roche.

The more global company allowed JeanMarie Guenot to travel to Shanghai. Her job at Hoffman exposed her to an entirely new side of her field. She was soon named Vice President of Corporate & Business Development for another company called PDL BioPharma. Her responsibility at PDL was to lead licensing, mergers and acquisitions, and alliance management groups.

And to think, her illustrious career started shortly her she graduated from the University of California, San Francisco, where she received her Ph.D. Guenot also attended The Wharton School at the University of Pennsylvania, where she earned her MBA. Her first job was at Atlas Venture, a small venture capital investments firm.

Lung Institute Leads Charge in Restorative Medicine

Cancer has remained the plight in which despite the amount of progress made in treatments continues to devastate millions of lives. Those fortunate enough to detect the cancer early enough while still being able to afford sufficient medical treatment still face a very steep upward climb towards reclaiming their health and lives. Many more instead spend their fight equally ravaged by the treatments used to destroy the cancer and the disease itself.

Chemotherapy and radiation treatment leave patients facing new debilitating symptoms caused leaving many facing no other decision but in which way they choose to suffer.

In a report by hawaiinewsnow.com, though breakthroughs in restorative and regenerative medicine may hold the key to beating cancer while not destroying the body simultaneously. Stem cell therapies could prove to be a vital tool in the arsenal for eliminating cancer while doctors research a cure.

Progress Moves Much Too Slow

Despite the possibility to save untold lives and forever change the way doctors treat one of the most dangerous afflictions facing our species funding is very limited and comes only from a few sources. As the treatment still faces a bit of resistance from many religious hardliners according to PR Web and the representatives that enact regulations in their name stem cell research suffers from a lack of government funding and subsidies.

Speaking to a pack auditorium in Italy during the Third International Congress on Responsible Stem Cell Research, the Lung Institute doctor and proponent for the benefits of stem cell therapies, Jack Coleman, Jr., M.D., raised the exact point that hindering the amount of good that can be accomplished with further advancements in the science is simply a lack of usable funds.

Dr. Coleman reminded the crowd gathered at the event that as doctors they must always be mindful of their duty to those that they treat. He further expressed, “Our responsibility is to give the best, safest treatment to patients to relieve pain and suffering and prolong quality of life”

The Lung Institute

The Lung Institute is leading the charge in cellular regenerative therapies aimed at treat those that suffer from pulmonary obstructions and other degenerative lung diseases. For more info, check out https://lunginstitute.com/. Also, check out their Facebook page.